Recruiting Clinical Trials

Clinical Trial of Intraperitoneal Hyperthermic Chemotherapy

By April 24, 2017 No Comments

Condition

Ovarian Cancer|Peritoneal Cancer|Fallopian Tube Cancer|Uterine Cancer|Mesotheliomas|Gastrointestinal Cancers|Cervical Cancer

Estimated Enrollment: 200

Age Group: 18 Years to 75 Years   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: No masking|Primary Purpose: Treatment

Study ID Numbers: HIPEC

Study First Received: December 22, 2014

Last Updated: January 30, 2017

Estimated Primary Completion Date: January 2018

 

Primary Outcome Measures:

measure treatment response to HIPEC and tumor debulking|Toxicity Monitoring

Sponsors and Collaborators:

Bay Area Gynecology Oncology

Website Link: https://ClinicalTrials.gov/show/NCT02349958

Leave a Reply

Call Now